123 related articles for article (PubMed ID: 10027661)
1. Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics.
Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
Eur J Clin Pharmacol; 1999 Jan; 54(11):857-64. PubMed ID: 10027661
[TBL] [Abstract][Full Text] [Related]
2. No clinically relevant effect of lornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamics.
Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
Eur J Clin Pharmacol; 1999 Jan; 54(11):865-8. PubMed ID: 10027662
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.
Kohl C; Steinkellner M
Drug Metab Dispos; 2000 Feb; 28(2):161-8. PubMed ID: 10640513
[TBL] [Abstract][Full Text] [Related]
4. Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon.
Russmann S; Dilger K; Trenk D; Nagyivanyi P; Jähnchen E
Arzneimittelforschung; 2001 Nov; 51(11):891-5. PubMed ID: 11765590
[TBL] [Abstract][Full Text] [Related]
5. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
Thijssen HH; Hamulyàk K
Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
[TBL] [Abstract][Full Text] [Related]
6. The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the dose.
van Geest-Daalderop JH; Hutten BA; Péquériaux NC; Haas FJ; Levi M; Sturk A
Thromb Haemost; 2007 Oct; 98(4):738-46. PubMed ID: 17938796
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxycoumarin oral anticoagulants: pharmacokinetics-response relationship.
Thijssen HH; Hamulyák K; Willigers H
Thromb Haemost; 1988 Aug; 60(1):35-8. PubMed ID: 3187945
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective interaction between piroxicam and acenocoumarol.
Bonnabry P; Desmeules J; Rudaz S; Leemann T; Veuthey JL; Dayer P
Br J Clin Pharmacol; 1996 Jun; 41(6):525-30. PubMed ID: 8799517
[TBL] [Abstract][Full Text] [Related]
9. Renal and gastrointestinal tolerability of lornoxicam, and effects on haemostasis and hepatic microsomal oxidation.
Warrington SJ; Lewis Y; Dawnay A; Johnston A; Kovacs IB; Lamb E; Ravic M
Postgrad Med J; 1990; 66 Suppl 4():S35-40. PubMed ID: 2284219
[TBL] [Abstract][Full Text] [Related]
10. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
Niopas I; Toon S; Aarons L; Rowland M
Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
[TBL] [Abstract][Full Text] [Related]
11. [The treatment basis for anticoagulants in horses].
Sinn D; Wintzer HJ
Tierarztl Prax; 1990 Oct; 18(5):507-11. PubMed ID: 2264055
[TBL] [Abstract][Full Text] [Related]
12. Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man.
Ehrlich A; Fuder H; Hartmann M; Wieckhorst G; Timmer W; Huber R; Birkel M; Bliesath H; Steinijans VW; Wurst W; Lücker PW
Eur J Clin Pharmacol; 1996; 51(3-4):277-81. PubMed ID: 9010699
[TBL] [Abstract][Full Text] [Related]
13. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of lornoxicam in man.
Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
[TBL] [Abstract][Full Text] [Related]
15. The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.
Jähnchen E; Meinertz T; Gilfrich HJ; Groth U; Martini A
Clin Pharmacol Ther; 1976 Sep; 20(3):342-9. PubMed ID: 954354
[TBL] [Abstract][Full Text] [Related]
16. The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.
Mönig H; Böhm M; Ohnhaus EE; Kirch W
Eur J Clin Pharmacol; 1990; 39(3):261-5. PubMed ID: 2257863
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.
Ravic M; Johnston A; Turner P
Postgrad Med J; 1990; 66 Suppl 4():S30-4. PubMed ID: 2126624
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteers.
Radhofer-Welte S; Dittrich P; Simin M; Branebjerg PE
Clin Drug Investig; 2008; 28(6):345-51. PubMed ID: 18479176
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
Skjodt NM; Davies NM
Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
[TBL] [Abstract][Full Text] [Related]
20. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
